Statistics about Health, Pharma & Medtech in United States
Statistics
- Kiromic Biopharma total equity 2019-2023
- Karyopharm Therapeutics total equity 2019-2023
- Alimera Sciences total equity 2019-2023
- Lisata Therapeutics, Inc. net income 2019-2023
- Alimera Sciences revenue 2019-2023
- Kronos Bio total equity 2019-2023
- Alimera Sciences net cash 2019-2023
- Kodiak Sciences total equity 2019-2023
- Kinnate Biopharma Inc. total equity 2019-2023
- Ligand Pharmaceuticals total assets 2019-2023
- Kintara Therapeutics total equity 2020-2024
- Kezar Life Sciences net income 2019-2023
- Alpine Immune Sciences total equity 2019-2023
- Alpine Immune Sciences total assets 2019-2023
- Alpine Immune Sciences net cash 2019-2023
- Alpine Immune Sciences revenue 2019-2023
- Alpine Immune Sciences liabilities 2019-2023
- Alpine Immune Sciences operating profit 2019-2023
- Kezar Life Sciences operating profit 2019-2023
- Kezar Life Sciences liabilities 2019-2023
- Sotera Health net cash 2019-2023
- Solid Biosciences net income 2019-2023
- Kezar Life Sciences net cash 2019-2023
- Sotera Health total assets 2020-2023
- Lisata Therapeutics, Inc. total equity 2019-2023
- Anaptysbio operating profit 2019-2023
- Lixte Biotechnology Holdings, Inc. operating profit 2019-2023
- Ardelyx total assets 2019-2023
- Ardelyx total equity 2019-2023
- Ardelyx net income 2016-2020
- Ardelyx revenue 2019-2023
- Ardelyx gross profit 2015-2019
- Healthy Extracts Inc. revenue 2019-2023
- Summit Therapeutics liabilities 2019-2023
- Lannett Company liabilities 2018-2022
- Kymera Therapeutics liabilities 2019-2023
- Kura Oncology, Inc. liabilities 2019-2023
- Ligand Pharmaceuticals operating profit 2019-2023
- Lipella Pharmaceuticals liabilities 2021-2023
- Healthy Extracts Inc. net income 2019-2023
- Landos Biopharma liabilities 2020-2023
- Solid Biosciences liabilities 2019-2023
- Sonnet Biotherapeutics Holdings, Inc. operating profit 2019-2023
- Lftd Partners Inc. operating profit 2019-2023
- Lipella Pharmaceuticals operating profit 2021-2023
- Lannett Company operating profit 2018-2022
- Landos Biopharma operating profit 2020-2023
- Sonoma Pharmaceuticals operating profit 2019-2023
- Kymera Therapeutics operating profit 2019-2023
- Sonoma Pharmaceuticals liabilities 2019-2023
- Lftd Partners Inc. liabilities 2019-2023
- Summit Therapeutics operating profit 2019-2023
- Summit Therapeutics net cash 2019-2023
- Lannett Company total assets 2018-2022
- Kymera Therapeutics total assets 2019-2023
- Solid Biosciences total assets 2019-2023
- Landos Biopharma total assets 2020-2023
- Sonnet Biotherapeutics Holdings, Inc. net cash 2019-2023
- Lixte Biotechnology Holdings, Inc. net cash 2019-2023
- Kura Oncology, Inc. total assets 2019-2023
- Sonoma Pharmaceuticals net cash 2019-2023
- Ligand Pharmaceuticals net cash 2019-2023
- Lipella Pharmaceuticals net cash 2021-2023
- Lftd Partners Inc. net cash 2019-2023
- Ardelyx operating profit 2019-2023
- Lannett Company net cash 2018-2022
- Solid Biosciences net cash 2019-2023
- Kura Oncology, Inc. net cash 2019-2023
- Landos Biopharma net cash 2020-2023
- Sonnet Biotherapeutics Holdings, Inc. liabilities 2019-2023
- Ardelyx liabilities 2019-2023
- Kymera Therapeutics net cash 2019-2023
- Lixte Biotechnology Holdings, Inc. liabilities 2014-2016
- Ardelyx net cash 2019-2023
- Ligand Pharmaceuticals liabilities 2019-2023
- Lftd Partners Inc. gross profit 2019-2023
- Heska Corp net income 2018-2022
- Anaptysbio revenue 2019-2023
- Ladrx liabilities 2019-2023
- Landos Biopharma net income 2020-2023
- Sonoma Pharmaceuticals revenue 2019-2023
- Summit Therapeutics revenue 2019-2023
- Lenz Therapeutics net cash 2020-2023
- Lenz Therapeutics total assets 2020-2023
- Lenz Therapeutics total equity 2019-2023
- Lenz Therapeutics operating profit 2020-2023
- Lenz Therapeutics net income 2020-2023
- Lenz Therapeutics liabilities 2020-2023
- Ladrx total assets 2019-2023
- Lisata Therapeutics, Inc. net cash 2019-2023
- Amgen net cash 2019-2023
- Anaptysbio total equity 2019-2023
- Ladrx total equity 2019-2023
- Ladrx net cash 2019-2023
- Lisata Therapeutics, Inc. total assets 2019-2023
- Lisata Therapeutics, Inc. operating profit 2019-2023
- Solid Biosciences revenue 2018-2022
- Ladrx revenue 2017-2018
- Lisata Therapeutics, Inc. liabilities 2019-2023
- Ladrx operating profit 2019-2023